Birdwatch Note Rating
2023-11-18 03:38:56 UTC - HELPFUL
Rated by Participant: EED233F51BF8FC932DF92BB3C38E4EC575236790133F1356D8D6C049F02CA864
Participant Details
Original Note:
In the trial the effectiveness of the vaccine against severe RSV disease in babies was 81.8%. The clinical trial efficacy & safety data is publicly available. The available data are insufficient to establish a causal relationship between preterm birth & the vaccine https://www.fda.gov/news-events/press-announcements/fda-approves-first-vaccine-pregnant-individuals-prevent-rsv-infants https://www.nejm.org/doi/10.1056/NEJMoa2216480 https://www.fda.gov/media/169361/download
All Note Details